Boston Scientific Corp. stock falls 2.50% amid continued market losses
Updated
Updated · MarketWatch · Apr 28
Boston Scientific Corp. stock falls 2.50% amid continued market losses
11 articles · Updated · MarketWatch · Apr 28
Shares closed at $58.45 on Tuesday, underperforming competitors as trading volume reached 16.9 million, above the 50-day average.
This marks the third consecutive day of losses for Boston Scientific, leaving the stock 46.62% below its 52-week high of $109.50 set in September.
While Abbott Laboratories gained 1.14%, other competitors like Medtronic and Stryker also declined, reflecting a generally grim day for the broader stock market.
With record earnings but a slashed forecast, is Boston Scientific a bargain or a falling knife?
Why do 99% of analysts rate Boston Scientific a 'BUY' while its stock is plummeting?
Can a $14.5 billion acquisition save Boston Scientific from its collapsing market share?
New data could quadruple a key device's market, so why are its sales suddenly declining?
How did competitors so quickly dismantle Boston Scientific's dominance in electrophysiology?